Candriam SCA’s Terns Pharmaceuticals TERN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$8.83M Buy
2,368,235
+214,266
+10% +$799K 0.05% 267
2025
Q1
$5.95M Hold
2,153,969
0.04% 298
2024
Q4
$11.9M Buy
+2,153,969
New +$11.9M 0.07% 240